|Articles|November 15, 2001
- BioPharm International-11-01-2001
- Volume 14
- Issue 11
Outsourcing Outlook: Truth in Outsourcing
Author(s)Jim Miller, William Bierce
by William Bierce and Jim Miller Is that great deal too good to be true?
Advertisement
Articles in this issue
almost 24 years ago
Business Matters: Eclipsed by Catastrophealmost 24 years ago
Designs for Bioassays with Plate Location Effectsalmost 24 years ago
Liposomes (a Review), Part One: Manufacturing Issuesalmost 24 years ago
Simplifying Pharmacologic Analysis with Programmable Scientific SoftwareNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
2
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
3
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
4
